"If a medical technology doesn't solve a problem you’ve personally managed in the OR, why is it anchoring your retirement portfolio?" In the professional landscape of March 2026, the gap between "clinical reality" and "financial speculation" has never been wider. While surgeons manage high-stakes variables with objective data, many physician investors remain passive passengers in their own portfolios—holding "Legacy MedTech" stocks currently being disrupted by the outpatient